TELL enables patients and clinicians to make timely decisions about brain health through automated speech analysis, a cutting-edge, non-invasive method to identify, discriminate, and monitor neurodegenerative diseases.
These disorders, including Alzheimer's and Parkinson's disease, affect 100 million people worldwide and cost over one trillion dollars annually in Latin America alone, creating an urgent need for inexpensive, flexible, and consistent markers that favor early detection.
Current diagnostic tools are slow, expensive, subjective, and often inaccessible to those in non-urban areas. This leads to expensive R&D, delayed treatments, and underserved patients. TELL offers a solution with automated, affordable, and scalable speech and language tests that use artificial intelligence to capture reliable markers of brain anomalies.
---
TELL permite tomar decisiones oportunas sobre la salud cerebral mediante análisis automatizados del habla, un método no invasivo de vanguardia para detectar, discriminar y monitorear enfermedades neurodegenerativas.
Dichas enfermedades, que incluyen al Alzheimer y al Parkinson, afectan a 100 millones de personas en el mundo y cuestan más de un billón de dólares al año solo en América Latina. Ello genera una urgencia por establecer marcadores económicos, flexibles y consistentes de tales trastornos.
Las herramientas de diagnóstico actuales son lentas, costosas, subjetivas y a menudo inaccesibles para aquellos fuera de grandes urbes. Esto encarece el desarrollo de nuevas drogas, demora los tratamientos y priva a múltiples pacientes de una atención a tiempop. TELL ofrece una solución con evaluaciones de habla automatizadas, asequibles y escalables que utilizan inteligencia artificial para captar marcadores confiables de anomalías cerebrales
Company Details
- Employees
- 13
- Founded
- -
- Address
- Buenos Aires, Ar
- Industry
- Mental Health Care
- NAICS
-
Offices of Mental Health Practitioners (except Physicians)
- Website
- http://tellapp.org
- Keywords
- Brain Health, AI, ML, Speech analysis.
- HQ
- Buenos Aires
Toolkit To Examine Lifelike Language (Tell) Questions
Toolkit To Examine Lifelike Language (Tell)'s website is http://tellapp.org
Toolkit To Examine Lifelike Language (Tell)'s LinkedIn profile is https://ar.linkedin.com/company/tell-biomarkers
Toolkit To Examine Lifelike Language (Tell) has
13 employees.
View email and phone details for 13
employees at Toolkit To Examine Lifelike Language (Tell).
Toolkit To Examine Lifelike Language (Tell)'s industry is
Mental Health Care
Toolkit To Examine Lifelike Language (Tell)'s top competitors are
Amplify Dynamics,
Hola René,
Eywa Biotech,
Millsonic,
The Ganesha Lab,
Nanotransfer,
Ophtavr,
Tintte,
Reliv,
Enlite Health Solutions.
Toolkit To Examine Lifelike Language (Tell)'s categories are Mental Health Care
Toolkit To Examine Lifelike Language (Tell)'s founding year is 2022
